JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hajime Ichikawa
Goro Matsumiya
Yoshiki Sawa
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torikai, K.
Right arrow Articles by Sawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Torikai, K.
Right arrow Articles by Sawa, Y.
Related Collections
Right arrow Peripheral vascular

J Thorac Cardiovasc Surg 2008;136:37-45
© 2008 The American Association for Thoracic Surgery

Surgery for Acquired Cardiovascular Disease

A self-renewing, tissue-engineered vascular graft for arterial reconstruction

Kei Torikai, MDa, Hajime Ichikawa, MD, PhDa, Koichiro Hirakawa, MSb, Goro Matsumiya, MD, PhDa, Toru Kuratani, MD, PhDa, Shigemitsu Iwai, MD, PhDa, Atsuhiro Saito, PhDa, Naomasa Kawaguchi, PhDc, Nariaki Matsuura, MD, PhDc, Yoshiki Sawa, MD, PhDa,*

a Division of Cardiovascular Surgery, Department of Surgery, Osaka University Graduate School of Medicine, Osaka, Japan
b Senko Medical Instrument Manufacturing Co Ltd, Tokyo, Japan
c Department of Pathology, Osaka University School of Allied Health Science, Osaka, Japan

Received for publication December 29, 2006; revisions received May 15, 2007; accepted for publication June 25, 2007.

* Address for reprints: Yoshiki Sawa, MD, PhD, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. (Email: sawa{at}surg1.med.osaka-u.ac.jp).

Objective: Various tissue-engineered vascular grafts have been studied to overcome the clinical disadvantages of conventional prostheses. Previous tissue-engineered vascular grafts have generally required preoperative cellular manipulation or use of bioreactors to improve performance, and their mechanical properties have been insufficient. We focused on the concept of in situ cellularization and developed a tissue-engineered vascular graft for arterial reconstruction that would facilitate renewal of autologous tissue without any pretreatment.

Methods: The graft comprised an interior of knitted polyglycolic acid compounded with collagen to supply a scaffold for tissue growth and an exterior of woven poly-L-lactic acid for reinforcement. All components were biocompatible and biodegradable, with excellent cellular affinity. The grafts, measuring 10 mm in internal diameter and 30 mm in length, were implanted into porcine aortas, and their utility was evaluated to 12 months after grafting.

Results: All explants were patent throughout the observation period, with no sign of thrombus formation or aneurysmal change. Presence in the neomedia of endothelialization with proper integrity and parallel accumulation of functioning smooth muscle cells, which responded to vasoreactive agents, was confirmed in an early phase after implantation. Sufficient collagen synthesis and lack of elastin were quantitatively demonstrated. Dynamic assessment and long-term results of the in vivo study indicated adequate durability of the implants.

Conclusion: The graft showed morphologic evidence of good in situ cellularization, satisfactory durability to withstand arterial pressure for 12 postoperative months, and the potential to acquire physiologic vasomotor responsiveness. These results suggest that our tissue-engineered vascular graft shows promise as an arterial conduit prosthesis.

Abbreviations and Acronyms ePTFE = expanded polytetrafluoroethylene; HUVEC = human umbilical vein endothelial cell; PGA = polyglycolic acid; PLLA = poly-L-lactic acid; SMC = smooth muscle cell; SNP = sodium nitroprusside; TEVG = tissue-engineered vascular graft




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
H. Takahashi, T. Yokota, E. Uchimura, S. Miyagawa, T. Ota, K. Torikai, A. Saito, K. Hirakawa, K. Kitabayashi, K. Okada, et al.
Newly developed tissue-engineered material for reconstruction of vascular wall without cell seeding.
Ann. Thorac. Surg., October 1, 2009; 88(4): 1269 - 1276.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.